Physiologically-based pharmacokinetic modeling for optimal dosage prediction of olaparib when co-administered with CYP3A4 modulators and in patients with hepatic/renal impairment

This study aimed to develop a physiologically-based pharmacokinetic (PBPK) model to predict the maximum plasma concentration (C(max)) and trough concentration (C(trough)) at steady-state of olaparib (OLA) in Caucasian, Japanese and Chinese. Furthermore, the PBPK model was combined with mean and 95%...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Dongmei, Wang, Guopeng, Wu, Honghai, Ren, Jiawei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10519932/
https://www.ncbi.nlm.nih.gov/pubmed/37749178
http://dx.doi.org/10.1038/s41598-023-43258-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10519932/
https://www.ncbi.nlm.nih.gov/pubmed/37749178
http://dx.doi.org/10.1038/s41598-023-43258-9

Ejemplares similares